ATAI Life Sciences BV Long-term Investment Intensity
ATAI Life Sciences BV long-term investment intensity. ATAI Life Sciences BV (ATAI) has a Long-term Investment Intensity of 2.6% as of March 2026. Long-term investments of $6.76 Million represent 2.6% of total assets of $264.88 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read ATAI total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of ATAI Life Sciences BV (2019–2025)
Long-term investment intensity of ATAI Life Sciences BV from 2019 to 2025. This chart shows how ATAI Life Sciences BV's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the intensity stands at 2.6%, reflecting long-term investments of $6.76 Million against total assets of $264.88 Million USD.
ATAI Life Sciences BV Long-term Investment Intensity by Year (2019–2025)
ATAI Life Sciences BV long-term investment intensity by year from 2019 to 2025. The table below presents the year-by-year Long-term Investment Intensity for ATAI Life Sciences BV from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ATAI Life Sciences BV (ATAI) total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 2.8% | $8.73 Million | $310.54 Million | ▼ -41.7 pp |
| 2024 | 44.5% | $70.97 Million | $159.39 Million | ▲ +13.3 pp |
| 2023 | 31.2% | $91.66 Million | $293.48 Million | ▲ +26.6 pp |
| 2022 | 4.6% | $14.02 Million | $305.44 Million | ▼ -2.1 pp |
| 2021 | 6.7% | $27.76 Million | $414.17 Million | ▼ -0.5 pp |
| 2020 | 7.2% | $8.04 Million | $111.55 Million | ▼ -29.7 pp |
| 2019 | 36.9% | $22.95 Million | $62.12 Million | — |